Bacteria possess specific enzymes capable of metabolizing glycation products, including amadoriases, glyoxalases, fructosamine kinases, and ribulosamine/erythrulosamine 3-kinases (152154)
They tend to be mild to moderate, and are more common when starting treatment or after a dose increase
Why Its GLP-1 Friendly: Lower-carb, easier on digestion, and perfect for preventing post-meal sluggishness
Symptoms may include: Severe insomnia
Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiency
In one study, participants lost an average of 15-20% of their body weight over 48 weeks